OH HB291

Prohibits health plan issuers from increasing cost-sharing burdens, moving drugs to more restrictive formulary tiers, or limiting coverage of prescription drugs during a plan year for plans amended, issued, or renewed after the bill's effective date.

Allows drug removal from formularies only if the FDA questions the drug's clinical safety, the manufacturer notifies the FDA of permanent discontinuance, or the manufacturer removes the drug from U.S. sale.

Permits pharmacists to substitute generic equivalent drugs or interchangeable biological products for prescribed drugs, and allows health plan issuers to require such substitutions when equivalents become available during a plan year.

Allows pharmacists to substitute alternative epinephrine autoinjectors pursuant to existing pharmacy law.

Classifies violations of these requirements as unfair and deceptive insurance practices subject to enforcement under Ohio's insurance law.